Politics
President Trump nominated Heidi Overton, a White House domestic policy aide, to be the next FDA commissioner, filling a vacancy left since Makary's resignation in May. Trump praised Overton's work on health initiatives including a vaccine schedule overhaul, food pyramid redesign, and drug pricing deals, while critics pointed to her opposition to abortion and past support for vaccine schedule changes that some doctors said lacked scientific backing.
Left-leaning outlets frame the nomination through Overton's ties to the anti-abortion movement and MAHA/MAGA ideology, highlighting her past statements celebrating the overturning of Roe v. Wade, criticism of Kamala Harris, and her role in promoting vaccine schedule changes that 'many doctors said were not supported by current science,' casting the pick as ideologically driven and controversial.
Center outlets report the nomination straightforwardly, emphasizing Overton's qualifications and the FDA's instability, while including both critical and supportive quotes (e.g., an industry analyst warning of 'anti-science and anti-vaccine' influence versus a conservative health-policy figure calling her a 'great choice'), presenting a balanced but somewhat skeptical tone about her readiness and confirmation prospects.
Right-leaning outlets frame the nomination positively, emphasizing Trump's praise of Overton as a 'ROCKSTAR' and her credentials and policy achievements (vaccine schedule overhaul, food pyramid redesign, drug pricing deals), while also noting potential confirmation friction with Sen. Cassidy and MAHA figures, but with less emphasis on abortion politics or scientific criticism.